Cytek Biosciences (CTKB) Preferred Dividend Payments (2020 - 2021)
Cytek Biosciences' (CTKB) quarterly Preferred Dividend Payments came in at -$1.2 million in Q4 2021, down 104.35% YoY from $27.4 million in Q4 2020, and down 210.89% on a QoQ basis from $1.1 million in Q3 2021.
Cytek Biosciences (CTKB) Preferred Dividend Payments (2020 - 2021) Analysis & Trends
Cytek Biosciences (CTKB) has 2 years of Preferred Dividend Payments data on file, last reported at -$1.2 million in Q4 2021.
- Quarterly Preferred Dividend Payments fell 104.35% year-over-year to -$1.2 million in Q4 2021, while the trailing twelve-month figure through Dec 2022 was -$1.2 million (down 103.98% YoY) and the FY2021 annual result came in at $3.0 million, down 81.47% from the prior year.
- Preferred Dividend Payments fell to -$1.2 million in Q4 2021, from $1.1 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $27.4 million in Q4 2020 to a low of -$6.2 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | - |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | - |
| 10 | Cytek Biosciences | 610.41 Mn | 536.56 Mn | 28.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -1.19 Mn |
| Sep 30, 2021 | 1.07 Mn |
| Jun 30, 2021 | 2.67 Mn |
| Dec 31, 2020 | 27.37 Mn |
| Sep 30, 2020 | -5.09 Mn |
| Jun 30, 2020 | -6.21 Mn |